FDA approves Aurobindo’s generic Vfend

SILVER SPRING, Md. — The Food and Drug Administration on Friday approved Aurobindo Pharma’s generic version of Vfend (Voriconazole) tablets. The drug is indicated to treat fungal infections in adults and children 12 years of age and older. 

 

The drug will be available in 50- and 200-mg dosage strengths, and total sales of voriconazole tablets were $102.7 million for the 12 months ended November 2015, according to IMS Health.